인쇄하기
취소

After Selection as a NIP, Sales of Prevenar 13 and Synflorix Had a Significant Increase

Published: 2014-09-12 15:38:28
Updated: 2014-09-12 15:38:28

After Pneumococcal vaccine was selected as a NIP (National Immunization Program) this May, Prevenar 13 of Pfizer and Synflorix of GSK have increased their sales as expected. However, Synflorix has attracted more attention as its market share has increased by 0.5%.

Looking at the market share after the NIP selection, both vaccines have increased their sales as expected. The vaccination became f...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.